- Previous Close
0.00 - Open
26.40 - Bid 26.80 x --
- Ask 29.95 x --
- Day's Range
26.40 - 26.40 - 52 Week Range
24.00 - 28.19 - Volume
2 - Avg. Volume
0 - Market Cap (intraday)
5.501B - Beta (5Y Monthly) 0.37
- PE Ratio (TTM)
7.99 - EPS (TTM)
3.40 - Earnings Date May 13, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date Jun 3, 2025
- 1y Target Est
--
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt. researches, develops, manufactures, markets, and sells pharmaceutical products in Europe, the Asia Pacific, North and Latin America, and internationally. It operates through two segments, Pharmaceuticals; and Wholesale and Retail. The company offers women's healthcare products for contraceptives, endometriosis, fertility, menopause, vaginal infections, and uterine fibroids, as well as Femtech, a digital therapeutic solution to enhance women's lives. It also provides central nervous system products, such as products for the treatment of chronic cerebral circulatory disorders and neuropathic pain; and anaesthetics, anti-anxiety medications, sleeping pills, and anti-epileptic medicines, as well as products for the prevention and treatment of various cardiovascular diseases. In addition, the company produces various over-the-counter products for various health problems comprising Panangin for heart support; Escapelle and Postinor, which are emergency contraceptive pills; Stopdiar and Nifuroxazide to treat diarrhea; RICHTER CycleBalance for infertility and PCOS; Curiosin for wound healing; Groprinosin for antiviral and immunostimulant; Folik, a pregnancy supplement; Moilec for back and joint pain; Fasconal, a pain relief tablet; Lordestin for allergies; Magnezin, a magnesium supplement; Aflamil, an anti-inflammatory and antirheumatic cream; and Oralsept, a sore throat and local anesthetic. Further, it engages in the provision of financial accounting, social and welfare, portfolio and management, catering, carriage transportation, engineering, quality control, asset management, and biotechnological manufacturing and research services; pharmaceutical retail; trading of biotech products; and sale of medical equipment. The company was formerly known as Gedeon Richter Ltd. Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt. was founded in 1901 and is headquartered in Budapest, Hungary.
www.gedeonrichter.com10,943
Full Time Employees
December 31
Fiscal Year Ends
Sector
Recent News: RGEDF
View MorePerformance Overview: RGEDF
Trailing total returns as of 4/17/2025, which may include dividends or other distributions. Benchmark is MSCI WORLD (^990100-USD-STRD) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: RGEDF
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: RGEDF
View MoreValuation Measures
Market Cap
5.18B
Enterprise Value
5.18B
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
--
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
27.90%
Return on Assets (ttm)
10.30%
Return on Equity (ttm)
19.58%
Revenue (ttm)
857.54B
Net Income Avi to Common (ttm)
239.24B
Diluted EPS (ttm)
3.40
Balance Sheet and Cash Flow
Total Cash (mrq)
135.64B
Total Debt/Equity (mrq)
7.65%
Levered Free Cash Flow (ttm)
134.09B